Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act: Section 1003 Demonstration Project to Increase Substance Use Provider Capacity | CMS 2C2 19 001

Opportunity Information: Apply for CMS 2C2 19 001

The grant opportunity titled "Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act: Section 1003 Demonstration Project to Increase Substance Use Provider Capacity" is a federal funding program administered by the U.S. Department of Health and Human Services (HHS) through the Centers for Medicare and Medicaid Services (CMS). It was released as a discretionary funding opportunity under Funding Opportunity Number CMS-2C2-19-001 and uses a cooperative agreement funding instrument, which generally means the federal agency expects to have an active role in guiding, monitoring, and collaborating with awardees during the project period rather than simply issuing funds with minimal involvement. The overall focus sits in the health category and is cataloged under CFDA number 93.664.

At its core, the program is designed to strengthen substance use disorder (SUD) treatment capacity by bringing more providers into the Medicaid service delivery system and increasing the ability of existing providers to serve Medicaid-enrolled individuals. The notice specifically solicits applications to participate in a "Demonstration Project to Increase Substance Use Provider Capacity" authorized by Section 1003 of the SUPPORT Act, a major federal law aimed at addressing the opioid crisis and improving access to prevention, treatment, and recovery supports. The emphasis on a demonstration project signals that CMS is looking not only to fund activities, but also to learn what works, measure results, and build evidence that can inform broader Medicaid policy and state-level approaches to addressing SUD workforce shortages and service gaps.

Eligibility is limited to state governments, reflecting the fact that Medicaid is state-administered within federal rules and that states are the entities positioned to make system-level changes to provider enrollment, credentialing, reimbursement, network adequacy, and delivery models. The opportunity anticipates making up to 10 awards, with an award ceiling of $5,000,000 per award. In practical terms, this creates a competitive environment where a limited number of states receive relatively sizable investments to implement and test strategies that expand SUD provider capacity. Because the funding is structured as a cooperative agreement, participating states should expect ongoing coordination with CMS, potentially including required reporting, technical assistance engagement, and alignment with federal evaluation priorities.

Key logistics provided in the source information include a creation date of June 25, 2019 and an original application closing date of August 9, 2019 (with no explanation listed for any changes). While the notice summary does not spell out specific allowable activities or required program components, its stated purpose clearly centers on increasing the number, availability, and readiness of substance use treatment providers serving Medicaid populations. This would generally encompass efforts that address workforce bottlenecks such as recruitment and retention, training and upskilling clinicians and support staff, expanding treatment settings and service lines, improving provider participation in Medicaid, and building delivery infrastructure that enables timely access to evidence-based SUD care, including opioid use disorder treatment and recovery supports. The overarching intent is to help states strengthen Medicaid's capacity to respond to SUD needs in communities by ensuring that more qualified providers are available to deliver treatment and support services where patients live and seek care.

• The Department of Health and Human Services, Centers for Medicare Medicaid Services in the health sector is offering a public funding opportunity titled "Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act: Section 1003 Demonstration Project to Increase Substance Use Provider Capacity" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.664.
• This funding opportunity was created on Jun 25, 2019.
• Applicants must submit their applications by Aug 09, 2019 No Explanation. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: State governments.

Apply for CMS 2C2 19 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: